A1RG34:BVMF
Argenx Se Bdr
201,80 BRL
0,00%
(0,00) 1 D
5. nov., 12:25:06 GMT-3 · BRL
search
Alle symboler
| Symbol | Pris | Endring | Endring (%) |
|---|
insights_autoGenererer viktig statistikk for A1RG34 …
Markedsverdi
59,39 mrd.
Snittvolum
38,00
Volum
0,00
52 u høy
213,15 BRL
52 u lav
143,22 BRL
Utestående aksjer
62,89 mill.
Antall ansatte
2k
Markedsverdi
59,39 mrd.
Snittvolum
38,00
Volum
0,00
52 u høy
213,15 BRL
52 u lav
143,22 BRL
Utestående aksjer
62,89 mill.
Antall ansatte
2k
Nyhetssaker
Fra nettkilder og nyhetspartnere
BioXconomy
·
for 27 minutter siden
Argenx buys into macrocyclic peptides with $1.15bn UNP deal
Pharmaceutical Executive
·
for 59 minutter siden
argenx Acquires Unnatural Products Inc. to Expand Immunology Capabilities
Yahoo Finance
·
for 5 timer siden
3 Reasons Argenx Could Be a Top Biotech Stock for the Next Decade
Investing.com
·
for 7 timer siden
Why is argenx stock surging today?
Profil
Argenx SE is a Belgian-Dutch pharmaceutical company specializing in immunology. Argenx specializes in the development of antibody therapies for the treatment of autoimmune diseases and cancer. Its work primarily focuses on the development of orphan drugs. Wikipedia
Om Argenx Se Bdr
Administrerende direktør-
Ansatte1,86k
Grunnlagt25. apr. 2008
Hovedkontor-
SektorHealth Care
Bransje-
Nettstedargenx.com